Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice
Red cell and platelet transfusions are essential in the management of people with haematological malignancies and bone marrow failure disorders. Up to 65% of platelet components and 25% of red cell components issued are given to haematology patients, and most are used in the elderly. As the UK popul...
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Wiley
2018
|
| _version_ | 1826282517132476416 |
|---|---|
| author | Estcourt, L Karakantza, M Grant-Casey, J Lowe, D Birchall, J |
| author_facet | Estcourt, L Karakantza, M Grant-Casey, J Lowe, D Birchall, J |
| author_sort | Estcourt, L |
| collection | OXFORD |
| description | Red cell and platelet transfusions are essential in the management of people with haematological malignancies and bone marrow failure disorders. Up to 65% of platelet components and 25% of red cell components issued are given to haematology patients, and most are used in the elderly. As the UK population is ageing, with a predicted doubling in people aged 85 years by 2041, only using red cell and platelet transfusion to those likely to benefit is imperative to minimise side effects, limit costs, and maintain the blood supply. |
| first_indexed | 2024-03-07T00:45:03Z |
| format | Conference item |
| id | oxford-uuid:8456ad73-2d5a-4f41-8a8c-a689d45a214e |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:45:03Z |
| publishDate | 2018 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:8456ad73-2d5a-4f41-8a8c-a689d45a214e2022-03-26T21:50:31ZTransfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practiceConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:8456ad73-2d5a-4f41-8a8c-a689d45a214eSymplectic Elements at OxfordWiley2018Estcourt, LKarakantza, MGrant-Casey, JLowe, DBirchall, JRed cell and platelet transfusions are essential in the management of people with haematological malignancies and bone marrow failure disorders. Up to 65% of platelet components and 25% of red cell components issued are given to haematology patients, and most are used in the elderly. As the UK population is ageing, with a predicted doubling in people aged 85 years by 2041, only using red cell and platelet transfusion to those likely to benefit is imperative to minimise side effects, limit costs, and maintain the blood supply. |
| spellingShingle | Estcourt, L Karakantza, M Grant-Casey, J Lowe, D Birchall, J Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title | Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title_full | Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title_fullStr | Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title_full_unstemmed | Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title_short | Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice |
| title_sort | transfusions in people with haematological malignancies results of a repeat uk national comparative audit with improvement in practice |
| work_keys_str_mv | AT estcourtl transfusionsinpeoplewithhaematologicalmalignanciesresultsofarepeatuknationalcomparativeauditwithimprovementinpractice AT karakantzam transfusionsinpeoplewithhaematologicalmalignanciesresultsofarepeatuknationalcomparativeauditwithimprovementinpractice AT grantcaseyj transfusionsinpeoplewithhaematologicalmalignanciesresultsofarepeatuknationalcomparativeauditwithimprovementinpractice AT lowed transfusionsinpeoplewithhaematologicalmalignanciesresultsofarepeatuknationalcomparativeauditwithimprovementinpractice AT birchallj transfusionsinpeoplewithhaematologicalmalignanciesresultsofarepeatuknationalcomparativeauditwithimprovementinpractice |